Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin

Anke Heida1, Els Van de Vijver2, Anneke Muller Kobold3

  • 1Department of Pediatric Gastroenterology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

BMJ Open
|May 31, 2017
PubMed

Insights

Faecal calgranulin C (S100A12) shows promise in diagnosing pediatric inflammatory bowel disease (IBD) more accurately than faecal calprotectin (FC). This study compares their effectiveness in children with gastrointestinal issues.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Biomarker Research

Background:

  • Faecal calprotectin (FC) aids in diagnosing pediatric inflammatory bowel disease (IBD) but often leads to unnecessary endoscopies.
  • Faecal calgranulin C (S100A12), a marker exclusively from activated granulocytes, may offer higher specificity for IBD.

Purpose of the Study:

  • To compare the diagnostic specificity and sensitivity of S100A12 against FC in children with suspected IBD.
  • To determine if S100A12 can improve diagnostic accuracy and reduce unnecessary invasive procedures.

Main Methods:

  • An international prospective cohort of children with suspected IBD was enrolled.
  • Patients were screened using both FC and S100A12 stool tests.
  • Diagnostic accuracy was assessed against reference standards (endoscopy and clinical follow-up).

Main Results:

  • The study aims to calculate and compare the specificity and sensitivity of S100A12 and FC.
  • Differences in diagnostic performance between the two markers will be quantified.

Conclusions:

  • S100A12 may be a more specific biomarker for pediatric IBD than FC.
  • This research could refine diagnostic pathways, potentially reducing invasive procedures for children with gastrointestinal complaints.
Abstract